Jagsonpal Pharmaceuticals Shareholding Pattern

As of Dec 2025, Jagsonpal Pharmaceuticals (JAGSNPHARM) promoter holding 67.39%, FII 2.12%, DII 0.15%, public 21.20%, total shareholders 24,895. For live price, key ratios and the full company profile, see JAGSNPHARM stock live price.

Promoter Holding 67.39%
FII Holding 2.12%
DII Holding 0.15%
Public Holding 21.20%
Total Shareholders 24,895
As of Dec 2025

JAGSNPHARM Recent Shareholding Changes — Promoter, FII & DII

Jagsonpal Pharmaceuticals promoter, FII and DII holding change from Sept 2025 to Dec 2025 — promoter -0.15%, DII +0.06%. Compare with Jagsonpal Pharmaceuticals value estimation to assess whether the stock is under or overvalued.

Promoter Holding Change
Sept 2025 to Dec 2025
-0.15%
FII Holding Change
Sept 2025 to Dec 2025
No Change
DII Holding Change
Sept 2025 to Dec 2025
+0.06%
Public Holding Change
Sept 2025 to Dec 2025
+0.07%

Jagsonpal Pharmaceuticals Quarterly Shareholding Trend — Promoter, FII, DII & Public

JAGSNPHARM promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Review JAGSNPHARM P/E comparison to evaluate earnings-based valuation against sector peers.

Promoter
FII
DII
Public
Government

JAGSNPHARM Shareholding Pattern Data — Quarterly History

Jagsonpal Pharmaceuticals quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 67.39% 2.12% 0.15% 0.00% 21.20% 9.14% 100.00% 24,895
Sept 2025 67.54% 2.12% 0.09% 0.00% 21.13% 9.12% 100.00% 24,653
Jun 2025 67.65% 2.18% 0.05% 0.00% 24.26% 5.86% 100.00% 22,899
Mar 2025 67.78% 2.10% 0.00% 0.00% 20.94% 9.17% 99.99% 21,085
Dec 2024 67.81% 2.10% 0.00% 0.00% 20.64% 9.45% 100.00% 18,471
Sept 2024 67.97% 2.30% 0.11% 0.00% 20.38% 9.24% 100.00% 15,633
Jun 2024 68.04% 1.10% 0.85% 0.00% 20.79% 9.22% 100.00% 15,748
Mar 2024 68.09% 0.73% 0.85% 0.00% 20.69% 9.64% 100.00% 16,282
Dec 2023 68.48% 0.00% 0.00% 0.00% 21.94% 9.58% 100.00% 15,785
Sept 2023 68.71% 0.38% 0.83% 0.00% 21.99% 8.09% 100.00% 16,041
Jun 2023 68.71% 0.00% 0.83% 0.00% 22.84% 7.62% 100.00% 13,782
Mar 2023 68.71% 0.00% 0.83% 0.00% 22.23% 8.23% 100.00% 14,084
Dec 2022 68.71% 0.00% 0.77% 0.00% 21.11% 9.40% 99.99% 14,952
Sept 2022 68.71% 0.13% 0.28% 0.00% 22.78% 8.10% 100.00% 16,194
Jun 2022 68.71% 0.00% 0.00% 0.00% 25.27% 6.02% 100.00% 17,100
Mar 2022 68.71% 0.00% 0.00% 0.00% 22.92% 8.36% 99.99% 20,031
Dec 2021 70.34% 0.20% 0.00% 0.00% 23.71% 5.75% 100.00% 14,353
Sept 2021 70.34% 0.11% 0.00% 0.00% 23.71% 5.83% 99.99% 14,655
Jun 2021 70.34% 0.00% 0.00% 0.00% 26.08% 3.57% 99.99% 12,546
Mar 2021 70.34% 0.00% 0.00% 0.00% 26.67% 2.98% 99.99% 0
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 67.39% 2.12% 0.15% 0.00% 21.20% 9.14% 100.00% 24,895
Sept 2025 67.54% 2.12% 0.09% 0.00% 21.13% 9.12% 100.00% 24,653
Jun 2025 67.65% 2.18% 0.05% 0.00% 24.26% 5.86% 100.00% 22,899
Mar 2025 67.78% 2.10% 0.00% 0.00% 20.94% 9.17% 99.99% 21,085
Dec 2024 67.81% 2.10% 0.00% 0.00% 20.64% 9.45% 100.00% 18,471
Sept 2024 67.97% 2.30% 0.11% 0.00% 20.38% 9.24% 100.00% 15,633
Jun 2024 68.04% 1.10% 0.85% 0.00% 20.79% 9.22% 100.00% 15,748
Mar 2024 68.09% 0.73% 0.85% 0.00% 20.69% 9.64% 100.00% 16,282
Dec 2023 68.48% 0.00% 0.00% 0.00% 21.94% 9.58% 100.00% 15,785
Sept 2023 68.71% 0.38% 0.83% 0.00% 21.99% 8.09% 100.00% 16,041
Jun 2023 68.71% 0.00% 0.83% 0.00% 22.84% 7.62% 100.00% 13,782
Mar 2023 68.71% 0.00% 0.83% 0.00% 22.23% 8.23% 100.00% 14,084
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 67.39% 2.12% 0.15% 0.00% 21.20% 9.14% 100.00% 24,895
Dec 2024 67.81% 2.10% 0.00% 0.00% 20.64% 9.45% 100.00% 18,471
Dec 2023 68.48% 0.00% 0.00% 0.00% 21.94% 9.58% 100.00% 15,785
Dec 2022 68.71% 0.00% 0.77% 0.00% 21.11% 9.40% 99.99% 14,952
Dec 2021 70.34% 0.20% 0.00% 0.00% 23.71% 5.75% 100.00% 14,353